• search
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

COVAXIN: Human trial of India's first Covid-19 vaccine begins at NIMS Hyderabad

|

Hyderabad, July 08: Indian Council for Medical Research (ICMR), in joint partnership with Bharat Biotech has developed India's first indigenous COVID-19 vaccine, Covaxin.

COVAXIN: Human trial of Indias first Covid-19 vaccine begins at NIMS Hyderabad

The process of conducting human clinical trials for Covaxin, a vaccine candidate for COVID-19, began on Tuesday at the Nizams Institute of Medical Sciences (NIMS) here, a top official of the state-run medical facility said.

"We will select healthy individuals and draw blood and send the blood samples to designated labs in New Delhi. They will give the green signal. Then the medicine people will examine and the first shot of the vaccine will be given due observation," NIMS director Dr K Manohar told PTI.

The Indian Council of Medical Research (ICMR) has identified 12 clinical trial sites such as medical institutions and hospitals, including NIMS, and has asked their principal investigators to ensure that the subject enrolment is initiated no later than July 7.

As per the ICMR guidelines, the enrollment process has already been started at AIIMS in Delhi and Patna. Also, all the mandatory preparation to start the human trials have already been completed at the Patna-AIIMS. The trials will begin from July 10 at the hospital.

"Everything will be sent to ICMR, where data is analysed. We have already started the screening of individuals. We will first take audio visual consent of the individual," the medical officer added.

    Government panel to handle investigations against 3 Gandhi family trusts | Oneindia News

    Asked about the total number of individuals required for the clinical trial, Manohar said at least 30 are needed. The clinical trials proposal was already placed before the NIMS hospital ethics committee.

    The Drug Controller General of India recently granted permission to initiate Phase I & II human clinical trials for COVID-19 Vaccine Covaxin- being developed by Bharat Biotech, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

    For Daily Alerts
    Get Instant News Updates
    Enable
    x
    Notification Settings X
    Time Settings
    Done
    Clear Notification X
    Do you want to clear all the notifications from your inbox?
    Settings X
    X
    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more